Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Molecular Cell|October 13, 2000
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesisB Goodwin, S A Jones, R R Price, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2021
Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activatorsAnthony B Pinkerton, E Hampton Sessions, Paul Hershberger, et al.
ACS Chemical Biology|April 28, 2016
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine AbuseLarry S Barak, Yushi Bai, Sean Peterson, et al.
Plos One|September 13, 2018
Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularizationDanielle McAnally, Khandaker Siddiquee, Ahmed Gomaa, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptorPatrick R Maloney, Pasha Khan, Michael Hedrick, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent modelDaniel J Price, David H Drewry, Lee T Schaller, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
Pageof 10